{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:08:47Z","timestamp":1773814127233,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012149","name":"National Key Scientific Instrument and Equipment Development Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22140903800"],"award-info":[{"award-number":["22140903800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFB3804504"],"award-info":[{"award-number":["2022YFB3804504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3401500"],"award-info":[{"award-number":["2022YFC3401500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0803201"],"award-info":[{"award-number":["2020YFA0803201"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004204","name":"Tongji University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004204","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341028"],"award-info":[{"award-number":["82341028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203505"],"award-info":[{"award-number":["82203505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101838"],"award-info":[{"award-number":["82101838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203367"],"award-info":[{"award-number":["82203367"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203520"],"award-info":[{"award-number":["82203520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.drup.2025.101318","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:01:56Z","timestamp":1762833716000},"page":"101318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Loss of cyclin C drives resistance to anti-TIGIT therapy by upregulating CD155-mediated immune evasion"],"prefix":"10.1016","volume":"84","author":[{"given":"Shiyu","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6182-5274","authenticated-orcid":false,"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zening","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zezhi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaohui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7234-3940","authenticated-orcid":false,"given":"Xudong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7637","key":"10.1016\/j.drup.2025.101318_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.drup.2025.101318_bib2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond immune checkpoint blockade: emerging immunological strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.drup.2025.101318_bib3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.ccell.2021.07.007","article-title":"The CD155\/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer","volume":"39","author":"Freed-Pastor","year":"2021","journal-title":"Cancer Cell"},{"issue":"6382","key":"10.1016\/j.drup.2025.101318_bib4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science (New York NY)"},{"issue":"8004","key":"10.1016\/j.drup.2025.101318_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-024-07121-9","article-title":"Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T(reg) cells","volume":"627","author":"Guan","year":"2024","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.drup.2025.101318_bib6","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.drup.2025.101318_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1574892818666230510124139","article-title":"Strategies for Developing Cancer Theranostics Approaches","volume":"19","author":"Wang","year":"2024","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"10","key":"10.1016\/j.drup.2025.101318_bib8","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/cas.13324","article-title":"CD155, an onco-immunologic molecule in human tumors","volume":"108","author":"Gao","year":"2017","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.drup.2025.101318_bib9","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1182\/blood-2005-07-2696","article-title":"Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction","volume":"107","author":"Pende","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101318_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2019.11.013","article-title":"Tumor intrinsic and extrinsic immune functions of CD155","volume":"65","author":"O'Donnell","year":"2020","journal-title":"Semin Cancer Biol."},{"issue":"4","key":"10.1016\/j.drup.2025.101318_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.immuni.2020.09.010","article-title":"CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8(+) T Cells","volume":"53","author":"Braun","year":"2020","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.drup.2025.101318_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)70060-4","article-title":"DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes","volume":"4","author":"Shibuya","year":"1996","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.drup.2025.101318_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.drup.2025.101318_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2478\/jtim-2023-0104","article-title":"The role of TIM3(+) NK and TIM3(-) NK cells in the immune pathogenesis of severe aplastic anemia","volume":"12","author":"Ding","year":"2024","journal-title":"J. Transl. Int Med"},{"issue":"3","key":"10.1016\/j.drup.2025.101318_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2022.02.005","article-title":"Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8(+) T cell responses","volume":"55","author":"Banta","year":"2022","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.drup.2025.101318_bib16","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.ccell.2024.10.008","article-title":"Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.drup.2025.101318_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-023-01800-3","article-title":"Co-inhibition of TIGIT and PD-1\/PD-L1 in cancer immunotherapy: mechanisms and clinical trials","volume":"22","author":"Chu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.drup.2025.101318_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(22)00226-1","article-title":"Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study","volume":"23","author":"Cho","year":"2022","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.drup.2025.101318_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.immuni.2022.12.010","article-title":"T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis","volume":"56","author":"Briukhovetska","year":"2023","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.drup.2025.101318_bib20","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1111\/cas.15921","article-title":"MicroRNA-326 negatively regulates CD155 expression in lung adenocarcinoma","volume":"114","author":"Nakanishi","year":"2023","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.drup.2025.101318_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.immuni.2020.11.002","article-title":"Genome-wide screens identify lineage- and tumor-specific genes modulating MHC-I- and MHC-II-restricted immunosurveillance of human lymphomas","volume":"54","author":"Dersh","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.drup.2025.101318_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An evolutionarily conserved function of polycomb silences the MHC Class I antigen presentation pathway and enables immune evasion in cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.drup.2025.101318_bib23","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","article-title":"A membrane-associated MHC-I inhibitory axis for cancer immune evasion","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.drup.2025.101318_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/geno.1996.0112","article-title":"Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors","volume":"32","author":"Li","year":"1996","journal-title":"Genomics"},{"issue":"6620","key":"10.1016\/j.drup.2025.101318_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn5647","article-title":"Enhanced T cell effector activity by targeting the Mediator kinase module","volume":"378","author":"Freitas","year":"2022","journal-title":"Science (New York NY)"},{"issue":"6546","key":"10.1016\/j.drup.2025.101318_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg0635","article-title":"Structures of the human Mediator and Mediator-bound preinitiation complex","volume":"372","author":"Chen","year":"2021","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.drup.2025.101318_bib27","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1093\/nar\/gkq029","article-title":"Preparation and topology of the Mediator middle module","volume":"38","author":"Koschubs","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.drup.2025.101318_bib28","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ncb3259","article-title":"The RNF138 E3 ligase displaces Ku to promote DNA end resection and regulate DNA repair pathway choice","volume":"17","author":"Ismail","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.drup.2025.101318_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.molcel.2023.11.034","article-title":"The UFM1 system: working principles, cellular functions, and pathophysiology","volume":"84","author":"Komatsu","year":"2024","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.drup.2025.101318_bib30","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1182\/blood-2005-04-1684","article-title":"Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor","volume":"107","author":"Tahara-Hanaoka","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.drup.2025.101318_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2022.02.005","article-title":"Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8(+) T cell responses","volume":"55","author":"Banta","year":"2022","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.drup.2025.101318_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.833","article-title":"Cyclin C: a new responser for chemosensitivity in cancer","volume":"12","author":"Fang","year":"2022","journal-title":"Clin. Transl. Med"},{"issue":"13","key":"10.1016\/j.drup.2025.101318_bib33","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1093\/nar\/gkab540","article-title":"Genome-wide CRISPR screens reveal cyclin C as synthetic survival target of BRCA2","volume":"49","author":"Tang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.drup.2025.101318_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.immuni.2020.09.010","article-title":"CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8(+) T cells","volume":"53","author":"Braun","year":"2020","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.drup.2025.101318_bib35","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1158\/1078-0432.CCR-19-3925","article-title":"Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma","volume":"26","author":"Lepletier","year":"2020","journal-title":"Clin. Cancer Res"},{"issue":"11","key":"10.1016\/j.drup.2025.101318_bib36","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ncb3046","article-title":"Cyclin C is a haploinsufficient tumour suppressor","volume":"16","author":"Li","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"15","key":"10.1016\/j.drup.2025.101318_bib37","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1093\/nar\/gkab628","article-title":"Loss of Cyclin C or CDK8 provides ATR inhibitor resistance by suppressing transcription-associated replication stress","volume":"49","author":"Lloyd","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.drup.2025.101318_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2174\/156800961508151001105814","article-title":"Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer","volume":"15","author":"Broude","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"issue":"7861","key":"10.1016\/j.drup.2025.101318_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41586-021-03555-7","article-title":"Structure of the human Mediator-RNA polymerase II pre-initiation complex","volume":"594","author":"Rengachari","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.drup.2025.101318_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jgg.2011.09.002","article-title":"Dysregulation of CDK8 and Cyclin C in tumorigenesis","volume":"38","author":"Xu","year":"2011","journal-title":"J. Genet Genom."},{"issue":"13","key":"10.1016\/j.drup.2025.101318_bib41","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/sj.onc.1208409","article-title":"Transcriptional activation of the mouse Necl-5\/Tage4\/PVR\/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway","volume":"24","author":"Hirota","year":"2005","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.drup.2025.101318_bib42","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41418-020-00660-4","article-title":"Fra-2\/AP-1 regulates melanoma cell metastasis by downregulating Fam212b","volume":"28","author":"Chen","year":"2021","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.drup.2025.101318_bib43","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1093\/nar\/gkab053","article-title":"Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers","volume":"49","author":"Bejjani","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.drup.2025.101318_bib44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13046-021-02162-8","article-title":"SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop","volume":"40","author":"Bian","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"18","key":"10.1016\/j.drup.2025.101318_bib45","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1182\/blood-2012-07-441022","article-title":"SOX4 is a direct target gene of FRA-2 and induces expression of HDAC8 in adult T-cell leukemia\/lymphoma","volume":"121","author":"Higuchi","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.drup.2025.101318_bib46","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","article-title":"Interferon-gamma induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation","volume":"81","author":"Yu","year":"2021","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.drup.2025.101318_bib47","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.celrep.2019.06.079","article-title":"CRISPR\/Cas9 screens reveal multiple layers of B cell CD40 regulation","volume":"28","author":"Jiang","year":"2019","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.drup.2025.101318_bib48","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ccell.2022.09.007","article-title":"Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses","volume":"40","author":"Chan","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101318_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101066","article-title":"Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance","volume":"73","author":"Gose","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101318_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101112","article-title":"Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane","volume":"76","author":"Zhang","year":"2024","journal-title":"Drug Resist Updat"},{"issue":"7","key":"10.1016\/j.drup.2025.101318_bib51","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.immuni.2022.05.012","article-title":"Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity","volume":"55","author":"Yang","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.drup.2025.101318_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/0008-5472.CAN-22-1829","article-title":"Sex hormones in breast cancer immunity","volume":"83","author":"Hargrove-Wiley","year":"2023","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.drup.2025.101318_bib53","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1158\/2159-8290.CD-23-0727","article-title":"So grateful for My X: sex chromosomes drive differences in glioblastoma immunity","volume":"13","author":"Alspach","year":"2023","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.drup.2025.101318_bib54","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.7150\/thno.106465","article-title":"Sex bias in tumor immunity: insights from immune cells","volume":"15","author":"Tao","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.drup.2025.101318_bib55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13046-021-02138-8","article-title":"Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA","volume":"40","author":"Mao","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:15:01Z","timestamp":1773810901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625001219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"alternative-id":["S1368764625001219"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101318","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of cyclin C drives resistance to anti-TIGIT therapy by upregulating CD155-mediated immune evasion","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101318"}}